blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1608362

EP1608362 - STABILIZED PHARMACEUTICAL PREPARATION COMPRISING AN AMORPHOUS ACTIVE SUBSTANCE [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  30.01.2015
Database last updated on 14.05.2024
Most recent event   Tooltip10.04.2015Lapse of the patent in a contracting state
New state(s): CH, LI
published on 13.05.2015  [2015/20]
Applicant(s)For all designated states
LEK Pharmaceuticals d.d.
Verovskova 57
1526 Ljubljana / SI
[2010/10]
Former [2007/21]For all designated states
LEK Pharmaceuticals d.d.
Verovskova 57
1526 Ljubljana / SI
Former [2005/52]For all designated states
Lek Pharmaceutical and Chemical Co. D.D.
Verovskova 57
1526 Ljubljana / SI
Inventor(s)01 / BASTARDA, Andrej
Podlipa 79
1360 Vrhnika / SI
02 / SALOBIR, Mateja
Ulica 28.maja 9
1000 Ljubljana / SI
03 / GRAHEK, Rok
Kaliska 9
4000 Kranj / SI
 [2005/52]
Representative(s)TBK
Bavariaring 4-6
80336 München / DE
[N/P]
Former [2010/44]TBK-Patent
Bavariaring 4-6
80336 München / DE
Former [2010/29]Chivarov, Georgi
TBK-Patent Bavariaring 4-6
80336 München / DE
Former [2010/10](deleted)
Former [2005/52]TBK-Patent
Bavariaring 4-6
80336 München / DE
Application number, filing date03770970.610.10.2003
[2005/52]
WO2003EP11265
Priority number, dateSI2002000024411.10.2002         Original published format: SI 200200244
[2005/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004032920
Date:22.04.2004
Language:EN
[2004/17]
Type: A1 Application with search report 
No.:EP1608362
Date:28.12.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 22.04.2004 takes the place of the publication of the European patent application.
[2005/52]
Type: B1 Patent specification 
No.:EP1608362
Date:21.02.2007
Language:EN
[2007/08]
Search report(s)International search report - published on:EP22.04.2004
ClassificationIPC:A61K31/40
[2005/52]
CPC:
A61K31/40 (EP,US); A61K9/2013 (EP,US); A61K9/2018 (EP,US);
A61K9/2054 (EP,US); A61P3/00 (EP); A61P3/06 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/52]
Extension statesAL23.03.2005
LT23.03.2005
LV23.03.2005
MK23.03.2005
TitleGerman:STABILISIERTE PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN AMORPHEN WIRKSTOFF[2005/52]
English:STABILIZED PHARMACEUTICAL PREPARATION COMPRISING AN AMORPHOUS ACTIVE SUBSTANCE[2005/52]
French:PREPARATION PHARMACEUTIQUE STABILISEE RENFERMANT UNE SUBSTANCE AMORPHE ACTIVE[2005/52]
Entry into regional phase23.03.2005National basic fee paid 
23.03.2005Designation fee(s) paid 
23.03.2005Examination fee paid 
Examination procedure21.04.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.03.2005Examination requested  [2006/10]
30.09.2005Observations by third parties
27.04.2006Observations by third parties
23.06.2006Communication of intention to grant the patent
02.11.2006Fee for grant paid
02.11.2006Fee for publishing/printing paid
Opposition(s)Opponent(s)01  03.05.2007  11.05.2007  WITHDRAWN
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Hoffmann Eitle, et al, et al
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
 02  20.11.2007  30.09.2014  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
 03  21.11.2007  28.11.2007  ADMISSIBLE
Miklich Laboratorios SA
Cuevas Bajas s/n - Of. 23 Edificio Picasso
29004 Malaga / ES
Opponent's representative
Gross, Ulrich-Maria, et al, et al
Uexküll & Stolberg Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
 [N/P]
Former [2014/45]
Opponent(s)01  03.05.2007  11.05.2007  WITHDRAWN
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Hoffmann Eitle, et al, et al
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
 02  20.11.2007  30.09.2014  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
 03  21.11.2007  28.11.2007  ADMISSIBLE
Miklich Laboratorios SA
Cuevas Bajas s/n - Of. 23 Edificio Picasso
29004 Malaga / ES
Opponent's representative
Gross, Ulrich-Maria, et al, et al
Uexküll & Stolberg, Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2012/26]
Opponent(s)01  03.05.2007  11.05.2007  WITHDRAWN
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
HOFFMANN EITLE, et al, et al
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
 02  20.11.2007  28.11.2007  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller Patentanwälte Unsöldstrasse 2
80538 München / DE
 03  21.11.2007  28.11.2007  ADMISSIBLE
Miklich Laboratorios SA
Cuevas Bajas s/n - Of. 23 Edificio Picasso
29004 Malaga / ES
Opponent's representative
Gross, Ulrich-Maria, et al, et al
Uexküll & Stolberg, Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2012/18]
Opponent(s)01  03.05.2007  11.05.2007  WITHDRAWN
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Wolf, Matthias, et al, et al
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
 02  20.11.2007  28.11.2007  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller Patentanwälte Unsöldstrasse 2
80538 München / DE
 03  21.11.2007  28.11.2007  ADMISSIBLE
Miklich Laboratorios SA
Cuevas Bajas s/n - Of. 23 Edificio Picasso
29004 Malaga / ES
Opponent's representative
Gross, Ulrich-Maria, et al, et al
Uexküll & Stolberg, Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2008/01]
Opponent(s)01  03.05.2007  11.05.2007  ADMISSIBLE
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Wolf, Matthias, et al, et al
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4
D-81925 München / DE
 02  20.11.2007  28.11.2007  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller Patentanwälte Prinzregentenstrasse 16
80538 München / DE
 03  21.11.2007  28.11.2007  ADMISSIBLE
Miklich Laboratorios SA
Cuevas Bajas s/n - Of. 23 Edificio Picasso
29004 Malaga / ES
Opponent's representative
Gross, Ulrich-Maria, et al, et al
Uexküll & Stolberg, Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2007/52]
Opponent(s)01  03.05.2007  11.05.2007  ADMISSIBLE
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Wolf, Matthias, et al, et al
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4
D-81925 München / DE
 02  20.11.2007   
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Best, Michael, et al, et al
Lederer & Keller Patentanwälte Prinzregentenstrasse 16
80538 München / DE
Former [2007/24]
Opponent(s)01  03.05.2007   
Zentiva a.s.
U kabelovny 130
102 37 Praha 10 / CZ
Opponent's representative
Wolf, Matthias, et al, et al
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4
D-81925 München / DE
02.01.2008Invitation to proprietor to file observations on the notice of opposition
11.07.2008Reply of patent proprietor to notice(s) of opposition
04.02.2010Date of oral proceedings
31.03.2010Despatch of interlocutory decision in opposition
31.03.2010Despatch of minutes of oral proceedings
16.10.2014Legal effect of revocation of patent [ N /P ]
16.10.2014Legal effect of revocation of patent [2015/10]
04.12.2014Despatch of communication that the patent will be revoked
Appeal following opposition27.05.2010Appeal received No.  T1007/10
10.08.2010Statement of grounds filed
16.10.2014Result of appeal procedure: revocation of the patent
26.05.2010Appeal received No.  T1007/10
10.08.2010Statement of grounds filed
16.10.2014Result of appeal procedure: revocation of the patent
22.04.2010Appeal received No.  T1007/10
10.08.2010Statement of grounds filed
16.10.2014Result of appeal procedure: revocation of the patent
09.06.2010Appeal received No.  T1007/10
09.08.2010Statement of grounds filed
16.10.2014Result of appeal procedure: revocation of the patent
16.10.2014Date of oral proceedings
22.10.2014Minutes of the oral proceedings despatched
Fees paidRenewal fee
31.10.2005Renewal fee patent year 03
31.10.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH21.02.2007
LI21.02.2007
LU10.10.2007
[2015/20]
Former [2009/39]LU10.10.2007
Cited inInternational search[A]GB1376362  (SADA P) [A] 1-27 * page 1, lines 8-12 ** page 1, lines 23-25 *;
 [A]DE2625164  (GOEDECKE AG) [A] 1-27 * page 3, paragraph 2 *;
 [X]US5682726  (GREEN PHILIP G [US], et al) [X] 1-27 * column 2, lines 25-59 * * figures 2,2A *;
 [X]WO0193859  (LEK TOVARNA FARMACEVTSKIH [SI], et al) [X] 1-28 * page 3, line 25 - page 4, line 2 * * page 9, lines 17-24 *;
 [X]US2002010357  (STOGNIEW MARTIN [US], et al) [X] 1-27 * paragraph [0072] * * examples 1,3 * * claim 19 *
ExaminationWO9703958
 EP1241110
    - LIEBERMAN H.A.; LACHMAN L., PHARMACEUTICAL DOSAGE FORMS, (1980), vol. 1, page 38
    - BOCCARDI G., IL FARMACO, (1994), vol. 49, pages 431 - 435
    - CORNELISSEN P.J.G., PHOTOCHEM AND PHOTOBIOL, (1979), vol. 30, pages 337 - 341
    - FLORENCE A.T.; ATTWOOD D., PHYSICOCHEMICAL PRINCIPLES OF PHARMACY, (2004), pages 103 - 105
    - JAVERNIK S. ET AL, PHARMAZIE, (2001), vol. 56, pages 738 - 740
    - KRISTENSEN S. ET AL, PHARMAZIE, (1998), vol. 53, pages 98 - 103
    - MAHAJAN R. ET AL, PHARM. RES., (2005), vol. 22, pages 128 - 140
    - TONNESEN H.H., PHARMAZIE, (1999), vol. 54, pages 590 - 594
    - TONNESEN H.H., INT. J. PHARM., (2001), vol. 225, pages 1 - 14
    - WATERMAN K.C., PHARM. DEV. TECH., (2002), vol. 7, pages 1 - 32
    - WATERMAN K.C.; ADAMI R.C., INT. J. PHARM., (2005), vol. 293, pages 101 - 125
otherWO9703958
 EP1241110
    - LIEBERMAN H.A. AND L. LACHMAN, "Pharmaceutical Dosage Forms Tablets", PHARMACEUTICAL DOSAGE FORMS, NEW YORK, (1980), vol. 1, page 1,2,38, XP002996804
    - VOIGT R., "PHARMAZEUTISCHE TECHNOLOGIE FUR STUDIUM UND BERUF", PHARMAZEUTISCHE TECHNOLOGIE FUR STUDIUM UND BERUF, (2000), page 1,2, 142-143, 477-478, 492,493, 543-544, XP002996805
    - BAUER K.H. ET AL, "LEHRBUCH DER PHARMAZEUTISCHEN TECHNOLOGIE Mit einer einfuhrung in die biopharmazie", LEHRBUCH DER PHARMAZEUTISCHEN TECHNOLOGIE, (2002), pages 1-3, 214-220 - 458, XP002996806
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.